- Home
- BRY vs CATX Comparison
BRY vs CATX Comparison
Compare BRY & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRY
- CATX
- Stock Information
- Founded
- BRY 1909
- CATX 1983
- Country
- BRY United States
- CATX United States
- Employees
- BRY N/A
- CATX N/A
- Industry
- BRY Oil & Gas Production
- CATX Medical/Dental Instruments
- Sector
- BRY Energy
- CATX Health Care
- Exchange
- BRY Nasdaq
- CATX Nasdaq
- Market Cap
- BRY 249.1M
- CATX 239.0M
- IPO Year
- BRY N/A
- CATX N/A
- Fundamental
- Price
- BRY $3.21
- CATX $3.47
- Analyst Decision
- BRY Buy
- CATX Strong Buy
- Analyst Count
- BRY 2
- CATX 11
- Target Price
- BRY $4.00
- CATX $12.90
- AVG Volume (30 Days)
- BRY 791.8K
- CATX 703.2K
- Earning Date
- BRY 11-06-2025
- CATX 08-13-2025
- Dividend Yield
- BRY 3.74%
- CATX N/A
- EPS Growth
- BRY N/A
- CATX N/A
- EPS
- BRY 0.07
- CATX N/A
- Revenue
- BRY $701,914,000.00
- CATX $1,235,000.00
- Revenue This Year
- BRY N/A
- CATX N/A
- Revenue Next Year
- BRY $1.15
- CATX N/A
- P/E Ratio
- BRY $49.27
- CATX N/A
- Revenue Growth
- BRY N/A
- CATX N/A
- 52 Week Low
- BRY $2.11
- CATX $1.60
- 52 Week High
- BRY $5.90
- CATX $16.31
- Technical
- Relative Strength Index (RSI)
- BRY 56.62
- CATX 45.81
- Support Level
- BRY $3.11
- CATX $3.20
- Resistance Level
- BRY $3.38
- CATX $3.68
- Average True Range (ATR)
- BRY 0.13
- CATX 0.24
- MACD
- BRY 0.03
- CATX -0.01
- Stochastic Oscillator
- BRY 72.58
- CATX 40.77
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.